PA
AGL icon

Parallel Advisors’s Agilon Health AGL Stock Holding History

Parallel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-312
Closed -$8.04K – 3623
2025
Q3 		$8.04K Buy
312
+209
+203% +$7.9K ﹤0.01% 2607
2025
Q2 		$5.95K Buy
103
+70
+212% +$5.61K ﹤0.01% 2674
2025
Q1 		$3.59K Buy
33
+26
+371% +$2.26K ﹤0.01% 2793
2024
Q4 		$334 Sell
7
-117
-94% -$7.07K ﹤0.01% 3302
2024
Q3 		$12.2K Sell
124
-30
-19% -$3.87K ﹤0.01% 2326
2024
Q2 		$25.2K Buy
154
+125
+431% +$17.8K ﹤0.01% 1856
2024
Q1 		$4.47K Buy
29
+26
+867% +$4.33K ﹤0.01% 2566
2023
Q4 		$966 Sell
3
-6
-67% -$2.17K ﹤0.01% 2942
2023
Q3 		$4.08K Buy
9
+3
+50% +$1.35K ﹤0.01% 2566
2023
Q2 		$2.57K Sell
6
-4
-40% -$2.25K ﹤0.01% 2678
2023
Q1 		$5.87K Buy
10
+4
+67% +$2.24K ﹤0.01% 2355
2022
Q4 		$2.45K Buy
6
+4
+200% +$1.88K ﹤0.01% 2607
2022
Q3 		$1K Buy
+2
New +$1.2K ﹤0.01% 2831
2022
Q2 		– Hold
0
– – – 2951
2022
Q1 		– Sell
-1
Closed -$515 – 2932
2021
Q4 		$1K Buy
+1
New +$608 ﹤0.01% 2812

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parallel Advisors's AGL Position: Q4 2025 in Review

Parallel Advisors sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 312 shares — an estimated $8.04K sold.

Parallel Advisors first reported a position in AGL in Q4 2021 and held it in 14 quarters. The position peaked at $25.2K in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Parallel Advisors reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Parallel Advisors sold 312 Agilon Health shares in Q4 2025, an estimated $8.04K.
  • Parallel Advisors first reported a position in Agilon Health in Q4 2021 and held it in 14 quarters.
  • Parallel Advisors's Agilon Health position peaked at $25.2K in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.